Growth hormone–releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice

JM Condor Capcha, A Kamiar… - Proceedings of the …, 2023 - National Acad Sciences
COVID-19 pneumonia causes acute lung injury and acute respiratory distress syndrome
(ALI/ARDS) characterized by early pulmonary endothelial and epithelial injuries with altered …

Infection with the SARS-CoV-2 B. 1.351 variant is lethal in aged BALB/c mice

F Yasui, Y Matsumoto, N Yamamoto, T Sanada… - Scientific Reports, 2022 - nature.com
Abstract Models of animals that are susceptible to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection can usefully evaluate the efficacy of vaccines and …

Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in …

G Granato, I Gesmundo, F Pedrolli, R Kasarla… - Frontiers in …, 2023 - frontiersin.org
COVID-19 is characterized by an excessive inflammatory response and macrophage
hyperactivation, leading, in severe cases, to alveolar epithelial injury and acute respiratory …

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model

WC Wei, KC Tsai, CC Liaw, CT Chiou… - Frontiers in …, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic continues to represent a challenge for
public health globally since transmission of different variants of the virus does not seem to …

[HTML][HTML] Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2

R Falach, L Bar-On, S Lazar, T Kadar, O Mazor… - JCI insight, 2021 - ncbi.nlm.nih.gov
Mice are normally unaffected by SARS coronavirus 2 (SARS-CoV-2) infection since the virus
does not bind effectively to the murine version of the angiotensin-converting enzyme 2 …

Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model

CJ Cáceres, S Cardenas-Garcia, S Carnaccini… - Scientific reports, 2021 - nature.com
The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) is the defining global health emergency of this century. GC-376 is a Mpro …

Suppression of miR-155 attenuates lung cytokine storm induced by SARS-CoV-2 infection in human ACE2-transgenic mice

DK Soni, J Cabrera-Luque, S Kar, C Sen, J Devaney… - BioRxiv, 2020 - biorxiv.org
ABSTRACT Coronavirus disease 2019 (COVID-19) is a recent global pandemic. It is a
deadly human viral disease, caused by the severe acute respiratory syndrome coronavirus 2 …

The infection and pathogenicity of SARS-CoV-2 variant B. 1.351 in hACE2 mice

Q Chen, XY Huang, Y Tian, C Fan, M Sun, C Zhou, R Li… - Virologica Sinica, 2021 - Springer
Since the outbreak of COVID-19 at the end of 2019, its causative agent SARS-CoV-2 has
been spreading around the world for one and half a year. During the long global circulation …

Pazopanib is a potential treatment for coronavirus-induced lung injuries

Y Luan, Q Yuan, Q Wang, S Compton… - The Journal of …, 2022 - journals.aai.org
Severe acute respiratory syndrome coronavirus 2, responsible for the severe acute
respiratory syndrome known as COVID-19, has rapidly spread in almost every country and …

Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose …

G Ewart, M Bobardt, BH Bentzen, Y Yan… - PLoS …, 2023 - journals.plos.org
The Coronavirus envelope (E) protein is a small structural protein with ion channel activity
that plays an important role in virus assembly, budding, immunopathogenesis and disease …